Skip to content

Multi-modal retinal assessment in early Alzheimer's disease and its clinical use

Multi-modal retinal assessment in early Alzheimer's disease and its clinical use

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037765
Enrollment
Unknown
Registered
2020-08-31
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early Alzheimer's disease

Interventions

Sponsors

Huashan Hospital Affiliated to Fudan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 50 to 85 years (inclusive) at the time of enrollment; 2. Male or female; 3. The AD, MCI and SCD; 3. subjects are diagnosed according to the NIA-AA 2011 criteria, Petersen/IWG 2004 criteria, Jessen SCD framework, respectively; 4. Have at least 6 years of education and have physical, hearing, speech, literacy and language capacity to participate in all neuropsychological testing; 5. Be able to cooperate in all the retinal imaging/assessment; 6. Willing and able to give informed consent by GCP and local guidance. The written informed consent signed by the participants or the legal representative.

Exclusion criteria

Exclusion criteria: 1. personal or family history of psychiatric disorders, Lewy body dementia, frontal temporal dementia, Vascular dementia, Parkinson's disease, Huntington disease, and Multiple Sclerosis, hydrocephalus, amongst others; 2. history of glaucoma, retinal detachment, optic neuropathy, other optic nerve diseases and retinal vascular disorders such as age-related macular degeneration, ocular trauma, a cataract that disturb visual and OCT examination, and other ocular disorders; 3. Major medical illnesses or unstable medical condition in the opinion of the investigator may interfere with the participants ability to comply. with study procedures.

Design outcomes

Primary

MeasureTime frame
Whether to convert to Alzheimer's disease dementia;

Contacts

Public ContactZhao Qianhua

Huashan Hospital Affiliated to Fudan Hospital

applenasa@hotmail.com+86 13671640216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026